Plott Ronald Toddinsider trades
In SEC Form 4 filings, Plott Ronald Todd is listed as Director of Phio Pharmaceuticals Corp. (PHIO). In the last 90 days, Plott Ronald Todd bought $10.3K of Phio Pharmaceuticals Corp. (PHIO) on the open market and sold none. The largest purchase was $5.2K of Phio Pharmaceuticals Corp. (PHIO) on Sep 29. Took part in a cluster buy; the latest at Phio Pharmaceuticals Corp. (PHIO), where 3 insiders bought within 8 days, ending Sep 29.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| PHIOPhio Pharmaceuticals Corp. | Director | 3 | Sep 30 |
Cluster buys
- PHIO: 3 insiders bought $19K between Sep 22 – Sep 29.
Form 4 historysince 2026-09-29
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| PHIOPhio Pharmaceuticals Corp. | Sep 29 | Sep 30 | P | 5,000 | $1.04 | Purchase +$5,200 | 42,000 | No | Form 4 |
| PHIOPhio Pharmaceuticals Corp. | Sep 28 | Sep 30 | P | 5,000 | $1.03 | Purchase +$5,150 | 37,000 | No | Form 4 |
| PHIOPhio Pharmaceuticals Corp. | Sep 28 | Sep 29 | A | 17,000 | $0.00 | $0 | 32,000 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.